Jump Financial, LLC Applied Therapeutics Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.35 - $8.5 $231,572 - $452,497	-53,235 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$4.04 - $6.37 $39,050 - $61,572	9,666 Added 22.19%	53,235 $248,000
Q1 2024 May 13, 2024	BUY	$2.25 - $7.4 $43,645 - $143,545	19,398 Added 80.25%	43,569 $296,000
Q4 2023 Oct 21, 2024	SELL	$1.84 - $3.35 $53,477 - $97,364	-29,064 Reduced 54.6%	24,171 $80,000
Q4 2023 Feb 07, 2024	BUY	$1.84 - $3.35 $44,474 - $80,972	24,171 New	24,171 $80,000

139

111M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $28.3M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.